IMPORTANT SAFETY INFORMATION

Text
Size
While it is not a cure, RILUTEK (riluzole) is the only FDA approved treatment for ALS.
It has been used in the US for 14 years.
If you have ALS, RILUTEK can give you more time. This extra time may offer you and
your loved ones the chance to adjust to the news and prepare for the future, while
still being able to plan events and activities with those who matter most to you.
There may be benefits to starting RILUTEK treatment as soon as possible. While it
is not a cure, RILUTEK has been shown to significantly extend the time before
invasive breathing assistance is needed and/or survival time (an average
of 2 to 3 months longer than people that took a
placebo). After 18 months of treatment, there was no difference between
those who took RILUTEK and those who took a placebo. What this means is that, in
clinical trials, RILUTEK offered a survival benefit early in ALS treatment.